Information Provided By:
Fly News Breaks for February 6, 2017
ATHN
Feb 6, 2017 | 09:08 EDT
Baird analyst Matthew Gillmor lowered his price target on athenahealth to $145 from $155 following worse than expected Q4 results, which were especially difficult given the positive updates mid-December and early January. Gillmor said he remains confident the company can inflect growth back towards 20% given its decent 2016 bookings performance. He thinks the medium-term risk/reward for the shares remains attractive despite negative sentiment. Gillmor maintained his Outperform rating on athenahealth shares.
News For ATHN From the Last 2 Days
There are no results for your query ATHN